Nektar Therapeutics
NASDAQ:NKTR
1.12 (USD) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 90.122 | 92.055 | 101.907 | 152.915 | 114.617 | 1,193.323 | 307.711 | 165.436 | 230.784 | 200.707 | 148.921 | 81.191 | 71.48 | 159.039 | 71.931 | 90.185 | 273.027 | 217.718 | 126.279 | 114.27 | 106.257 | 94.845 | 77.468 | 51.629 | 41.358 | 21.795 | 16.249 | 6.9 | 3.4 | 1.7 |
| Cost of Revenue
| 36.644 | 21.635 | 24.897 | 19.477 | 21.374 | 24.412 | 30.547 | 30.215 | 34.102 | 28.533 | 38.509 | 30.428 | 21.891 | 25.667 | 30.948 | 35.037 | 147.517 | 118.089 | 35.996 | 19.798 | 14.678 | 7.02 | 4.169 | 0 | 0 | 0 | 0 | -1.2 | -1.1 | -0.5 |
| Gross Profit
| 53.478 | 70.42 | 77.01 | 133.438 | 93.243 | 1,168.911 | 277.164 | 135.221 | 196.682 | 172.174 | 110.412 | 50.763 | 49.589 | 133.372 | 40.983 | 55.148 | 125.51 | 99.629 | 90.283 | 94.472 | 91.579 | 87.825 | 73.299 | 51.629 | 41.358 | 21.795 | 16.249 | 8.1 | 4.5 | 2.2 |
| Gross Profit Ratio
| 0.593 | 0.765 | 0.756 | 0.873 | 0.814 | 0.98 | 0.901 | 0.817 | 0.852 | 0.858 | 0.741 | 0.625 | 0.694 | 0.839 | 0.57 | 0.611 | 0.46 | 0.458 | 0.715 | 0.827 | 0.862 | 0.926 | 0.946 | 1 | 1 | 1 | 1 | 1.174 | 1.324 | 1.294 |
| Reseach & Development Expenses
| 111.286 | 218.323 | 400.269 | 408.678 | 434.566 | 399.536 | 268.461 | 203.801 | 182.787 | 147.734 | 190.01 | 148.675 | 126.766 | 108.065 | 95.109 | 154.417 | 153.575 | 149.381 | 151.659 | 133.523 | 131.528 | 157.383 | 139.651 | 101.544 | 64.083 | 35.398 | 23.645 | 14.4 | 9 | 0 |
| General & Administrative Expenses
| 77.417 | 92.333 | 122.844 | 104.682 | 98.712 | 81.443 | 52.364 | 44.275 | 43.266 | 40.925 | 40.532 | 41.614 | 46.76 | 40.986 | 41.006 | 51.497 | 56.336 | 78.319 | 43.852 | 30.967 | 22.017 | 26.016 | 18.861 | 13.932 | 7.869 | 8.387 | 6.328 | 4 | 0 | 0 |
| Selling & Marketing Expenses
| 2.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 79.617 | 92.333 | 122.844 | 104.682 | 98.712 | 81.443 | 52.364 | 44.275 | 43.266 | 40.925 | 40.532 | 41.614 | 46.76 | 40.986 | 41.006 | 51.497 | 56.336 | 78.319 | 43.852 | 30.967 | 22.017 | 26.016 | 18.861 | 13.932 | 7.869 | 8.387 | 6.328 | 4 | 3.2 | 7.4 |
| Other Expenses
| -6.247 | -0.116 | -24.41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.392 | 0.983 | 0 | 0 | 0 | -68.114 | -48.253 | 31.159 | 69.546 | 3.924 | 4.219 | 4.507 | 25.49 | 0 | 0 | 0 | 0 | 1.2 | 4.3 | 7.9 |
| Operating Expenses
| 190.903 | 310.656 | 523.113 | 513.36 | 533.278 | 480.979 | 320.825 | 248.076 | 226.053 | 188.659 | 230.542 | 190.289 | 173.526 | 149.051 | 136.115 | 137.8 | 161.658 | 258.859 | 265.057 | 168.414 | 157.764 | 187.906 | 184.002 | 115.476 | 71.952 | 43.785 | 29.973 | 19.6 | 13.3 | 7.9 |
| Operating Income
| -137.425 | -240.236 | -446.103 | -379.922 | -440.035 | 687.932 | -59.642 | -112.855 | -29.371 | -16.485 | -120.13 | -141.201 | -123.937 | -28.255 | -95.132 | -82.652 | -36.148 | -159.23 | -182.633 | -73.942 | -66.185 | -100.081 | -256.963 | -66.139 | -40.484 | -21.99 | -13.724 | -11.5 | -8.8 | -5.7 |
| Operating Income Ratio
| -1.525 | -2.61 | -4.378 | -2.485 | -3.839 | 0.576 | -0.194 | -0.682 | -0.127 | -0.082 | -0.807 | -1.739 | -1.734 | -0.178 | -1.323 | -0.916 | -0.132 | -0.731 | -1.446 | -0.647 | -0.623 | -1.055 | -3.317 | -1.281 | -0.979 | -1.009 | -0.845 | -1.667 | -2.588 | -3.353 |
| Total Other Income Expenses Net
| -138.831 | -124.747 | -77.177 | -64.025 | -0.019 | -5.207 | -15.981 | -39.793 | -14.079 | -37.943 | 0.392 | -0.692 | -1.044 | -11.749 | 0.848 | 118.321 | 50.332 | -25.017 | -74.751 | -8.962 | 32.209 | -0.996 | -150.455 | -41.984 | -9.89 | 0 | 0 | 1.6 | 1.3 | 0.6 |
| Income Before Tax
| -276.256 | -364.983 | -523.28 | -443.947 | -440.054 | 682.725 | -96.076 | -152.648 | -80.671 | -54.428 | -159.768 | -171.449 | -132.96 | -37.057 | -102.772 | 35.142 | -31.452 | -153.933 | -185.248 | -102.049 | -46.513 | -107.468 | -250.008 | -97.403 | -50.374 | 0 | 0 | -9.9 | -7.5 | -5.1 |
| Income Before Tax Ratio
| -3.065 | -3.965 | -5.135 | -2.903 | -3.839 | 0.572 | -0.312 | -0.923 | -0.35 | -0.271 | -1.073 | -2.112 | -1.86 | -0.233 | -1.429 | 0.39 | -0.115 | -0.707 | -1.467 | -0.893 | -0.438 | -1.133 | -3.227 | -1.887 | -1.218 | 0 | 0 | -1.435 | -2.206 | -3 |
| Income Tax Expense
| -0.2 | 3.215 | 0.557 | 0.493 | 0.613 | 1.412 | 0.616 | 0.876 | 0.506 | -0.512 | 2.245 | 0.406 | 1.018 | 0.881 | -0.253 | -0.806 | 1.309 | 0.828 | -0.137 | -0.163 | 0.169 | 7.387 | 139.305 | 33.556 | 7.854 | -3.634 | -3.741 | -1.5 | -1.1 | -0.4 |
| Net Income
| -276.056 | -368.198 | -523.837 | -444.44 | -440.667 | 681.313 | -96.692 | -153.524 | -81.177 | -53.916 | -162.013 | -171.855 | -133.978 | -37.938 | -102.519 | -34.336 | -32.761 | -154.761 | -185.111 | -101.886 | -46.682 | -107.468 | -250.008 | -97.403 | -38.448 | -18.356 | -9.983 | -10 | -7.7 | -5.3 |
| Net Income Ratio
| -3.063 | -4 | -5.14 | -2.906 | -3.845 | 0.571 | -0.314 | -0.928 | -0.352 | -0.269 | -1.088 | -2.117 | -1.874 | -0.239 | -1.425 | -0.381 | -0.12 | -0.711 | -1.466 | -0.892 | -0.439 | -1.133 | -3.227 | -1.887 | -0.93 | -0.842 | -0.614 | -1.449 | -2.265 | -3.118 |
| EPS
| -1.45 | -1.97 | -2.86 | -2.49 | -2.52 | 3.78 | -0.62 | -1.1 | -0.61 | -0.42 | -1.4 | -1.5 | -1.19 | -0.4 | -1.11 | -0.37 | -0.36 | -1.72 | -2.15 | -1.3 | -0.84 | -1.94 | -4.71 | -2.32 | -1.13 | -0.58 | -0.36 | -0.44 | -0.39 | -0.43 |
| EPS Diluted
| -1.45 | -1.97 | -2.86 | -2.49 | -2.52 | 3.78 | -0.62 | -1.1 | -0.61 | -0.42 | -1.4 | -1.5 | -1.19 | -0.4 | -1.11 | -0.37 | -0.36 | -1.72 | -2.15 | -1.3 | -0.84 | -1.94 | -4.71 | -2.32 | -1.13 | -0.58 | -0.36 | -0.44 | -0.39 | -0.43 |
| EBITDA
| -129.61 | -220.539 | -453.798 | -347.458 | -380.544 | 736.373 | -24.4 | -95.117 | -14.836 | -2.744 | -104.731 | -121.72 | -106.742 | 2.417 | -76.563 | -178.484 | -58.326 | -101.578 | -73.792 | -45.793 | -79.977 | -80.116 | 80.137 | -11.739 | -13.45 | -18.392 | -11.286 | -11.9 | -9 | -5.8 |
| EBITDA Ratio
| -1.438 | -2.396 | -4.453 | -2.272 | -3.32 | 0.617 | -0.079 | -0.575 | -0.064 | -0.014 | -0.703 | -1.499 | -1.493 | 0.015 | -1.064 | -1.979 | -0.214 | -0.467 | -0.584 | -0.401 | -0.753 | -0.845 | 1.034 | -0.227 | -0.325 | -0.844 | -0.695 | -1.725 | -2.647 | -3.412 |